General
Preferred name
DIQUAFOSOL
Synonyms
Diquas ()
DIQUAFOSOL TETRASODIUM ()
INS-365 ()
Dicuafosol ()
DIQUAFOSOL TETRASODIUM SALT ()
DIQUAFOSOL SODIUM ()
INS365 ()
INS 365 ()
DE-089 ()
KPY-998 ()
Diquafosol (sodium salt) ()
P&D ID
PD050276
CAS
59985-21-6
211427-08-6
Tags
available
drug candidate
drug
Approved by
PMDA
First approval
2010
Drug indication
Dry eye disease
Drug Status
experimental
approved
investigational
Max Phase
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION The USAN specifies the tetrasodium salt formulation. (GtoPdb)
Compound Sets
16
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
EUbOPEN Chemogenomics Library
Guide to Pharmacology
Natural product-based probes and drugs
Selleckchem Bioactive Compound Library
External IDs
56
Properties
(calculated by RDKit )
Molecular Weight
789.99
Hydrogen Bond Acceptors
21
Hydrogen Bond Donors
10
Rotatable Bonds
14
Ring Count
4
Aromatic Ring Count
2
cLogP
-4.19
TPSA
404.45
Fraction CSP3
0.56
Chiral centers
12.0
Largest ring
6.0
QED
0.08
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
purinergic receptor activator
Biosynthetic Origin
Nucleoside
Therapeutic Indication
Dry Eye Syndrome
Target
P2 Receptor
Recommended Cell Concentration
None
Source data